Definitive Contract 36C25723C0035

Award Date 1/18/23
Potential Completion Date 3/17/23
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The contract has a potential value of $532,198.27 and a completion date of January 31, 2025. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. and is a major supplier of radiopharmaceuticals and specialized pharmaceutical products to...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, with a ceiling value of $517,056.85, is for the supply of radiopharmaceuticals to the VA's Veterans Integrated Service Network 8. This is a firm fixed-price purchase order contract, with an ultimate completion date of November 14, 2017. The contract is not set aside for any specific business type. Cardinal Health 414 is an established...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals and has a potential value of $109,544.44. It is a firm fixed price delivery order contract with no set-aside designation. Cardinal Health 414 has been awarded multiple indefinite delivery vehicle (IDV) contracts to provide radiopharmaceuticals and related...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $57,000.00, is for the delivery of radiopharmaceuticals, radioactive isotopes, and other specialty pharmaceutical products to support nuclear medicine, oncology, and patient care programs at VA facilities. Cardinal Health 414 has extensive experience...
This firm fixed-price federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $369,141.65, is for the provision of radiopharmaceuticals to support the VA's nuclear medicine and oncology programs. Cardinal Health 414 has previously delivered radiopharmaceuticals, diagnostic imaging agents, and specialty pharmaceuticals to various federal health agencies,...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract, valued at $641,293.32, is a definitive contract with a firm fixed-price pricing type and a period of performance through October 19, 2020. This award is not associated with a set-aside designation. Cardinal Health 414 is a major supplier of critical medical isotopes and radiopharmaceutical...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The contract, valued at $385,268.49, has a completion date of June 5, 2022. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. The company has delivered radiopharmaceuticals, diagnostic imaging agents, nuclear medicine supplies, and specialty...
This federal contract award is for the delivery of various radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract, valued at $795,997.00, was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a performance period through September 30, 2025 and is structured as a delivery order with a firm fixed-price pricing type. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and diagnostic imaging...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals. The contract, valued at $713,585.56, is a delivery order issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA). The contract has an ultimate completion date of September 30, 2024, and is structured as a firm fixed-price arrangement. This award does not have a set-aside designation, indicating Cardinal...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, which has no set-aside designation, is for the delivery of radiopharmaceuticals and nuclear medicine supplies to support VA healthcare facilities. The potential value of the contract is $192,841.66, with a completion date of September 30, 2018. Cardinal Health 414 holds several indefinite...

This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17 to Cardinal Health 414, LLC for the delivery of radiopharmaceuticals. The contract has a potential value of $52,948.10 and a completion date of March 17, 2023. It is a firm-fixed-price contract with no set-aside designation.

Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. and a major supplier of radiopharmaceuticals and related products to federal health agencies, including the VA, Department of Defense (DOD), and National Institutes of Health (NIH). The company holds several indefinite delivery vehicle (IDV) contracts with the VA to provide radiopharmaceuticals and related services to VA medical facilities nationwide, with values up to $39.8 million. This specific award is likely to support the VA's nuclear medicine, oncology, and other patient care programs through the delivery of products such as technetium-99m, iodine-123, iodine-131, and other radioactive drugs used for diagnostic imaging and radiopharmaceutical therapies.

Generated 5/19/24, 12:18 AM